The Zoe Report explores the growing demand for regenerative skincare treatments.
“One of the market leaders is Elevai Skincare, which is sold primarily through doctors’ offices and went public on the Nasdaq recently under the ticker symbol ELAB.” – The Zoe Report
The article highlighted Elevai’s patent-pending formulas, including our post-procedure professional treatment and at-home serum.
By combining exosomes with ceramides, vitamin C, glutathione, and peptides, Elevai products target redness, pigmentation, and fine lines while supporting more resilient skin. This recognition reinforces Elevai’s role in driving the future of science-backed, regenerative aesthetics. Read the full article on The Zoe Report.
Meet Cell Zero Exosomes™
Derived from Human Umbilical Mesenchymal Stem Cell Conditioned Media, our exosomes contain native proteins and growth factors (EGF, FGF, VEGF, TGF-β) that visibly enhance skin tone, texture, and overall radiance. Ethically sourced and biologically aligned with human skin.